Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study. (Q44086731)
Jump to navigation
Jump to search
scientific article published on 23 May 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study. |
scientific article published on 23 May 2013 |
Statements
Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study (English)
Valentina Lukashevich
Wolfgang Kothny
Marie-José Hoellinger
Päivi Maria Paldánius